Dm1

DIABETES MELLITUS WITH PERIPHERAL NEUROPATHY

Presented by: Amol Lavate

PATIENT DEMOGRAPHICS IP number  Patient’s age  Gender  Date of admission  Date of discharge 

: : : : :

336223 62 yrs Male 13.10.09 01.11.09

SUBJECTIVE EVIDENCES Ø c/o : ØPedal edema and pain ,from 7 days ØGiddiness on walking ØProblem in urination 

 

OBJECTIVE EVIDENCES

BLOOD GLUCOSE LEVEL MONITERING

DATE

FBS (mg/dl)

PLRBS (mg/dl)

PDRBS (mg/dl)

UNIT OF INSULIN GIVEN

14/10/09

251

-

84

-

15/10/09

224

118

192

-

16/10/09

205

284

125

0-8-0

17/10/09

191

265

183

4-10-4

18/10/09

225

184

256

6-4-10

19/10/09 20/10/09 21/10/09

236 216 229

232 254 210

184 280 191

8-8-4 6-10-0 6-10-12

22/10/09

246

180

249

8-10-12

24/10/09 25/10/09 27/10/09

107 119 -

90 99

89 -

-

28/1o/09 29/10/09 30/10/09 31/10/09 01/10/09

115 112 112 100 111

-

115 -

-

LABORATORY DATA ANALYSIS 

    

DATE Glucose (60-160mg/dl) Hb(11.5-18gm%) ESR(1-15mm/hr)

13/10/09 225 10.6 58

ASSESMENT OF THERAPEUTIC GOALS 

To bring blood sugar level normal  To provide treatment for DM with neuropathy 

   

ASSESMENT OF CURRENT THERAPY Medication(strenth,dose,r Date oute,dosage) started Tab Amlodipine 5mg 13.10.09 1-0-0 Inj.optineuron I.M(OD) 13.10.09 Inj. Human insulin 13.10.09 Tab.Metformin 500mg 24.10.09 1-0-1 Tab.Gabapentin 300mg 13.10.09 1-0-1 Tab. Ciprofloxacin 13.10.09 500mg 1-0-1 Cap.Tolterodine 4mg 13.10.09 1-0-1

Date stopped DM 02.11.09 23.10.09 DM DM 02.11.09 DM

Indication Antihypertensive Nutrition Anti-diabetic Anti-diabetic Anticonvulsant Antimicrobial Urogenitail antispasmodic

THERAPEUTIC MONITORING   

Blood Glucose level monitored

TOXICITY MONITORING 

Blood sugar level monitored daily

PLANNING 

Discharge medication :Tab.Amlodep-AT-5mg 1-0-0 Tab.Glycomet.500mg 1-0-1 Tab. Gabaneuran. 300mg 1-0-1 Cap.TORQ-S.R- 4mg 1-0-0 

   

Follow up after 8 days

PATIENT COUNSELLING 

Disease :



 

Drugs :



  

Life style modifications :

THANK YOU